loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 207997 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Novartis Pharmaceuticals Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVARTIS (1)

    filter

    01 CAPSULE;ORAL (1)

    filter

    01 RX (1)

    filter

    01 RYDAPT (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MIDOSTAURIN

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE; ORAL
    25MG
    2017-04-28
    207997
    RYDAPT
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 207997

    Looking for FDA Orange Book APPLICATION 207997 1

    19

    Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is MIDOSTAURIN, with a corresponding application number 207997.

    Regulatory Information RX

    With a dosage strength 25MG

    Dosage Form Route CAPSULE; ORAL

    Reference Listed Drug Yes

    Approved since 2017-04-28

    Post Enquiry
    POST ENQUIRY